The angiotensin-receptor blocker telmisartan did no better than placebo in reducing cardiovascular events in high-risk patients intolerant to ACEs. cheap Colchicine
1 Vote(s)
Similar Posts
- Reducing cardiovascular risk through a nurse-led email reminder program
- PREDICTing Heart Attacks – the 9 billion dollar question.
- Putting Guidelines into Practice
- Bringing “the Egypt” to Indigenous Youth Health
- Managing High Risk Asthma in Primary Care
